Results 121 to 130 of about 48,365 (251)

Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT There is a need to better understand the indications and safety profiles for therapeutic plasma exchange (TPE) in children. We aimed to assess pediatric TPE practice at a large academic center by retrospective chart review from 2011 to 2022. Patient demographics and clinical information including American Society for Apheresis (ASFA) category ...
Benjamin C. Lee   +4 more
wiley   +1 more source

Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT The objective of this in vitro experimental was to determine the utility of hemoadsorption (HA) using the CytoSorb adsorber to remove meloxicam and diclofenac from porcine plasma. For this purpose 12 1‐L aliquots of porcine plasma, 6 units were spiked with 293 μg/mL (262–320 μg/mL) diclofenac and 6 with 42.8 μg/mL (41.4–44.7 μg/mL) meloxicam ...
Bettina Giani   +3 more
wiley   +1 more source

Multiple Oral and Eyelid Nodules in a Pediatric Patient

open access: yes
Oral Diseases, EarlyView.
Caique Mariano Pedroso   +10 more
wiley   +1 more source

Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
A patient with Bipolar I disorder developed manic symptoms following the initiation of brivaracetam for focal epilepsy. Although brivaracetam is generally considered to have favorable psychiatric tolerability, this case highlights a potential risk of mood destabilization in patients with underlying bipolar disorder.
Mihoko Kawai   +2 more
wiley   +1 more source

Narrative review of strategies for blood product shelf‐life extension

open access: yes
Transfusion, EarlyView.
Mike Akaraphanth   +7 more
wiley   +1 more source

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

open access: yesArthritis &Rheumatology, Volume 78, Issue 5, Page 1176-1183, May 2026.
Objective Transition from long‐term denosumab (Dmab) to parathyroid hormone‐analogs or romosozumab (Romo) might expose patients to the risk of the so‐called rebound phenomenon. Adding Romo to Dmab might represent an option in patients experiencing a fracture while on Dmab.
Giovanni Adami   +10 more
wiley   +1 more source

Vitamin D Deficiency is Associated with Hypocalcemia in Preterm Infants

open access: yesMCBS (Molecular and Cellular Biomedical Sciences)
Background: Vitamin D deficiency results in various problems, like rickets, osteomalacia, heart problems, cancer, diabetes, and autoimmune diseases. Hypocalcemia is a common disorder among preterm infants, indicating vitamin D deficiency.
Nabiel Nabiel   +2 more
doaj   +1 more source

فراوانی کاهش غلظت کلسيم سرم ناشی از فوتوتراپی در نوزادان ايکتريک بستری در بيمارستان شهيد اکبرآبادی [PDF]

open access: yes, 2010
زمينه و هدف: فوتوتراپی نقش قابل ملاحظه‌ای در درمان و پيشگيری هيپربيليروبينميای نوزادان دارد. اگرچه اين روش منجر به بروز برخی عوارض نيز می‌گردد که از جمله عوارض کمتر شايع فوتوتراپی، هيپوکلسمی می‌باشد.
احسانی‌پور, فهیمه   +2 more
core  

Management of neonatal massive hemorrhage: A narrative review

open access: yes
Transfusion, EarlyView.
Cheryl S. L. Chooi   +7 more
wiley   +1 more source

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Review of Types, Pathophysiology, and Treatment Approaches

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy